Ocumension Therapeutics
Known title: DirectorCIK: 0001840315
Associated companies
Transaction History
| EYPT | ▼ Sell | Open Market | 1,910,500 | $37.2M | 1/11/2024 | View on chart |
| EYPT | ▼ Sell | Open Market | 266,242 | $4.9M | 12/6/2023 | View on chart |
| EYPT | ▼ Sell | Open Market | 733,758 | $14.6M | 12/5/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Yahoo article highlights EYPT as a potential portfolio addition
A recent Yahoo article discussed EyePoint Inc. (EYPT) and listed reasons why the stock could be considered for a portfolio. The piece referenced the company's analyst consensus target of $25.91 and its 52‑week range of $2.93 to $19.11. The article’s positive tone adds to current market conversation around the stock.
Yahoo article highlights EYPT as a potential portfolio addition. A recent Yahoo article discussed EyePoint Inc. (EYPT) and listed reasons why the stock could be considered for a portfolio. The piece referenced the company's analyst consensus target of $25.91 and its 52‑week range of $2.93 to $19.11. The article’s positive tone adds to current market conversation around the stock.